Drareg
Member
- Joined
- Feb 18, 2016
- Messages
- 4,772
Let’s unpack this madness, actually in second though let’s not, it speaks for itself.
Over to you in the COVID cult to explain this one, perhaps just have faith it’s covid and enjoy your victim status, punish yourself with this infection and you will become one of us, it’s like hazing at this point, some sort of weird induction to a cult via pain, you don’t even need symptoms , just use your mental anguish and rage against those who won’t mask up.
It takes too long to sequence, they can’t be bothered yet they are bothered about 24/7 variant narratives in media in such a confident manner.
We are told the vaccines are ineffective against the delta variant, is this a cover for the vaccines are ineffective against covid19? This would explain the legal block on knowing.
This article may have just let that slip, just like many have spotted the pathological desire to have everyone vaccinated is to eliminate a control group that may end up health while the vax cult are sick.
I mean who made this piece of legislation? When we find out the usual links to the ruling class will be found.
@haidut
www.businessinsider.com
Reider assumed it was because authorities wanted to find out whether he had a Delta infection. He, too, was curious — but when he got the test results back, he was surprised to learn that doctors couldn't give him any information about his variant.
"When I got the follow-up from Kaiser, they said it's positive, but they didn't have any of the sequencing information," Reider told Insider. That "felt odd to me," he said.
Several legal barriers prevented Reider and his doctors — as well as nearly all Americans who have tested positive for the coronavirus — from knowing which variant was to blame.
So far, Wroblewski said, more than 50 public labs in the US are capable of sequencing coronavirus samples to detect variants. But she's not aware of any labs that have completed the validation process to get federal approval.
"The process of validating a next-generation sequencing test is burdensome," Wroblewski said. "It takes a lot of time. It takes a lot of data. It takes a lot of resources. And the thing about the variants is that variants of concern and of interest are constantly changing, so you would have to do a whole validation every time you have a variant."
For a sequencing test to be validated, a manufacturer needs to collect data to show that the test does a good job of detecting a specific variant, then request emergency authorization from the Food and Drug Administration. Alternatively, laboratories can validate their sequencing tests "in house," meaning they collect the same data so CMS can approve their test.
"The letter of the law from CMS is that if you don't go through this full validation process, you cannot release the results with patient identifying information," Wroblewski said. One major exception, she noted, is if epidemiologists need to disclose a person's variant information over the course of contact tracing.
Validating a test for a single variant could take weeks to months, she added.
"To keep up with it in real time, when it doesn't influence a decision you're going to make on how you treat a patient, just isn't very useful," Wroblewski said. "It's satisfying curiosity more than it's really benefiting a patient."
But right now, variants haven't fundamentally changed the way people protect themselves from COVID-19. Though the Delta variant is the most contagious version of the virus yet, masks and social distancing still reduce its spread. And COVID-19 vaccines continue to offer good protection against severe disease and death.
"At this point, unless we see something that truly is going to direct your therapeutic choice at an individual patient level, there's not a lot of benefit to a physician or a patient in knowing you have Delta," Wroblewski said. "There's nothing differently that a physician is going to do to treat that patient."
That makes it hard to justify the time and expense of a validating a test, she added — particularly when those resources could be used to do more sequencing.
"If we see later there's going to be true impact on a therapeutic that's used to treat SARS-CoV-2, then yes, we'll very likely change our approach," Wroblewski said. "But at this moment, we're not there yet."
Over to you in the COVID cult to explain this one, perhaps just have faith it’s covid and enjoy your victim status, punish yourself with this infection and you will become one of us, it’s like hazing at this point, some sort of weird induction to a cult via pain, you don’t even need symptoms , just use your mental anguish and rage against those who won’t mask up.
It takes too long to sequence, they can’t be bothered yet they are bothered about 24/7 variant narratives in media in such a confident manner.
We are told the vaccines are ineffective against the delta variant, is this a cover for the vaccines are ineffective against covid19? This would explain the legal block on knowing.
This article may have just let that slip, just like many have spotted the pathological desire to have everyone vaccinated is to eliminate a control group that may end up health while the vax cult are sick.
I mean who made this piece of legislation? When we find out the usual links to the ruling class will be found.
@haidut
You aren't legally allowed to know which variant gave you COVID-19 in the US, even if it's Delta
Sequencing tests, which pick up on variants, have to be federally approved before their results can be disclosed to doctors or patients.
www.businessinsider.com
- Most people with COVID-19 in the US are legally prevented from knowing which variant infected them.
- That's because sequencing tests have to be federally approved for results to be disclosed to doctors or patients, and most are not yet.
- Lab scientists say the process of validating the tests for approval is too costly and time-consuming.
Reider assumed it was because authorities wanted to find out whether he had a Delta infection. He, too, was curious — but when he got the test results back, he was surprised to learn that doctors couldn't give him any information about his variant.
"When I got the follow-up from Kaiser, they said it's positive, but they didn't have any of the sequencing information," Reider told Insider. That "felt odd to me," he said.
Several legal barriers prevented Reider and his doctors — as well as nearly all Americans who have tested positive for the coronavirus — from knowing which variant was to blame.
So far, Wroblewski said, more than 50 public labs in the US are capable of sequencing coronavirus samples to detect variants. But she's not aware of any labs that have completed the validation process to get federal approval.
"The process of validating a next-generation sequencing test is burdensome," Wroblewski said. "It takes a lot of time. It takes a lot of data. It takes a lot of resources. And the thing about the variants is that variants of concern and of interest are constantly changing, so you would have to do a whole validation every time you have a variant."
For a sequencing test to be validated, a manufacturer needs to collect data to show that the test does a good job of detecting a specific variant, then request emergency authorization from the Food and Drug Administration. Alternatively, laboratories can validate their sequencing tests "in house," meaning they collect the same data so CMS can approve their test.
"The letter of the law from CMS is that if you don't go through this full validation process, you cannot release the results with patient identifying information," Wroblewski said. One major exception, she noted, is if epidemiologists need to disclose a person's variant information over the course of contact tracing.
Validating a test for a single variant could take weeks to months, she added.
"To keep up with it in real time, when it doesn't influence a decision you're going to make on how you treat a patient, just isn't very useful," Wroblewski said. "It's satisfying curiosity more than it's really benefiting a patient."
But right now, variants haven't fundamentally changed the way people protect themselves from COVID-19. Though the Delta variant is the most contagious version of the virus yet, masks and social distancing still reduce its spread. And COVID-19 vaccines continue to offer good protection against severe disease and death.
"At this point, unless we see something that truly is going to direct your therapeutic choice at an individual patient level, there's not a lot of benefit to a physician or a patient in knowing you have Delta," Wroblewski said. "There's nothing differently that a physician is going to do to treat that patient."
That makes it hard to justify the time and expense of a validating a test, she added — particularly when those resources could be used to do more sequencing.
"If we see later there's going to be true impact on a therapeutic that's used to treat SARS-CoV-2, then yes, we'll very likely change our approach," Wroblewski said. "But at this moment, we're not there yet."
